Multi-Omics Profiling for Health

被引:89
|
作者
Babu, Mohan [1 ]
Snyder, Michael [1 ]
机构
[1] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94304 USA
基金
美国国家卫生研究院;
关键词
INTEGRATIVE ANALYSIS; CHROMATIN IMMUNOPRECIPITATION; REGULATORY VARIATION; MASS-SPECTROMETRY; PHYSICAL-ACTIVITY; PERSONAL OMICS; RNA; BINDING; METABOLOMICS; OPPORTUNITIES;
D O I
10.1016/j.mcpro.2023.100561
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The world has witnessed a steady rise in both non-infectious and infectious chronic diseases, prompting a cross-disciplinary approach to understand and treating disease. Current medical care focuses on treating people after they become patients rather than preventing illness, leading to high costs in treating chronic and late-stage diseases. Additionally, a "one-size-fits all" approach to health care does not take into account individual differ-ences in genetics, environment, or lifestyle factors, decreasing the number of people benefiting from in-terventions. Rapid advances in omics technologies and progress in computational capabilities have led to the development of multi-omics deep phenotyping, which profiles the interaction of multiple levels of biology over time and empowers precision health approaches. This review highlights current and emerging multi-omics mo-dalities for precision health and discusses applications in the following areas: genetic variation, cardio-metabolic diseases, cancer, infectious diseases, organ trans-plantation, pregnancy, and longevity/aging. We will briefly discuss the potential of multi-omics approaches in dis-entangling host-microbe and host-environmental in-teractions. We will touch on emerging areas of electronic health record and clinical imaging integration with muti-omics for precision health. Finally, we will briefly discuss the challenges in the clinical implementation of multi-omics and its future prospects.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Multi-Omics Profiling of Lumacaftor/Ivacaftor Response in Cystic Fibrosis
    Kopp, B. T.
    Fitch, J. R.
    Zhang, S.
    Shrestha, C. L.
    Woodley, F. W.
    Hayes, D.
    White, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [22] MOPED 2.5-An Integrated Multi-Omics Resource: Multi-Omics Profiling Expression Database Now Includes Transcriptomics Data
    Montague, Elizabeth
    Stanberry, Larissa
    Higdon, Roger
    Janko, Imre
    Lee, Elaine
    Anderson, Nathaniel
    Choiniere, John
    Stewart, Elizabeth
    Yandl, Gregory
    Broomall, William
    Kolker, Natali
    Kolker, Eugene
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2014, 18 (06) : 335 - 343
  • [23] Survey on Multi-omics, and Multi-omics Data Analysis, Integration and Application
    Shahrajabian, Mohamad Hesam
    Sun, Wenli
    CURRENT PHARMACEUTICAL ANALYSIS, 2023, 19 (04) : 267 - 281
  • [24] Are multi-omics enough?
    Cristina Vilanova
    Manuel Porcar
    Nature Microbiology, 1 (8)
  • [25] Multi-Omics Approaches for Exploring Health Implications: A Review
    Potta, Swaraj
    Biswas, Kamalika
    Kumar, Aayush Sasi
    Yogesh, Venkata Sai
    Krishna, Sai Neeraj
    Tabassum, Syed Sana
    Siddiqui, Nadeem
    ASIAN JOURNAL OF PHARMACEUTICS, 2023, 17 (04) : 681 - 683
  • [26] Are multi-omics enough?
    Vilanova, Cristina
    Porcar, Manuel
    NATURE MICROBIOLOGY, 2016, 1 (08)
  • [27] CLINICAL MULTI-OMICS
    Radstake, Timothy R.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 16 - 16
  • [28] Multi-omics profiling predicts allograft function after lung transplantation
    Watzenboeck, Martin L.
    Gorki, Anna-Dorothea
    Quattrone, Federica
    Gawish, Riem
    Schwarz, Stefan
    Lambers, Christopher
    Jaksch, Peter
    Lakovits, Karin
    Zahalka, Sophie
    Rahimi, Nina
    Starkl, Philipp
    Symmank, Doerte
    Artner, Tyler
    Pattaroni, Celine
    Fortelny, Nikolaus
    Klavins, Kristaps
    Frommlet, Florian
    Marsland, Benjamin J.
    Hoetzenecker, Konrad
    Widder, Stefanie
    Knapp, Sylvia
    EUROPEAN RESPIRATORY JOURNAL, 2022, 59 (02)
  • [29] Multi-omics profiling of extended honeymoon unveils new therapeutic targets
    Abdelsalam, A.
    Loretelli, C.
    Ben Nasr, M.
    Usuelli, V.
    Assi, E.
    Zocchi, M.
    Petrazzuolo, A.
    Nardini, M.
    Lodovichi, S.
    Petitti, A.
    Cannalire, G.
    D'Addio, F.
    Mameli, C.
    Fiorina, P.
    DIABETOLOGIA, 2024, 67 : S171 - S171
  • [30] Deep Multi-Omics Profiling in Cytogenetically Poor-Risk AML
    Rio-Machin, Ana
    Bewicke-Copley, Findlay
    Zheng, Jiexin
    Izquierdo, Pedro Casado
    Miettinen, Juho J.
    Khan, Naeem
    Demeulemeester, Jonas
    Krizsan, Szilvia
    Middleton, Christopher
    Benkwitz-Bedford, Sam
    Saad, Joseph
    Vilas-Zornoza, Amaia
    Ezponda, Teresa
    Grey, William
    Lavallee, Vincent-Philippe
    Nolin-Lapalme, Alexis
    Miraki-Moud, Farideh
    Matthews, Janet
    Grantham, Marianne
    Colm, Ryan J.
    Bond, Jonathan
    Di Bella, Doriana
    Wennerberg, Krister
    Parsons, Alun
    Zeng, Andy G. X.
    Armes, Hannah
    Close, Karina
    Kaya, Fadimana
    Rouault-Pierre, Kevin
    Gribben, John G.
    Prosper, Felipe
    Cavenagh, James
    Dick, John E.
    Freeman, Sylvie D.
    Van Loo, Peter
    Bodor, Csaba
    Sauvageau, Guy
    Porkka, Kimmo
    Heckman, Caroline A.
    Wang, Jun
    Cazier, Jean-Baptiste
    Taussig, David
    Bonnet, Dominique
    Cutillas, Pedro
    Fitzgibbon, Jude
    BLOOD, 2022, 140 : 1030 - 1032